Comparing side effects of two prostate cancer radiation treatments
Part of Cancer, Kidney & urinary clinical trials.
This study compares the side effects of two types of radiation therapy for prostate cancer that hasn't spread. It aims to help doctors and patients choose the treatment with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older.
- You have low or intermediate risk prostate cancer (Gleason score 3+3 or 3+4, PSA 20 or less, and the cancer is confined to the prostate).
- You have not had previous treatment for prostate cancer or radiation to the pelvis.
- You have not had hormone therapy for prostate cancer, and you don't need it now.
- You are generally in good health with a life expectancy of at least 10 years.
- You don't have significant urinary symptoms (IPSS score 15 or less).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a lower dose of radiation can effectively treat prostate cancer while reducing side effects. It is for men with certain types of prostate cancer that are visible on an MRI.
This trial tests whether a shorter course of radiation works as well as the usual longer course for people with high-risk prostate cancer. The goal is to keep cancer control while possibly reducing treatment time and inconvenience.
This trial studies a more sped-up radiation schedule for men with certain local prostate cancers, given together with hormone therapy. It aims to keep cancer control while possibly reducing treatment time and making care easier.
This trial compares two types of radiation therapy (SBRT and LDR brachytherapy) for men with low-risk or favorable intermediate-risk prostate cancer. The goal is to see which treatment causes fewer side effects.
This study compares two ways of giving radiation to the prostate, including a “boost” using a special internal radiation treatment. It’s meant to see which radiation schedule works better and is safer for certain prostate cancer patients.
This trial compares two types of radiation treatments for prostate cancer that has not spread to lymph nodes or other parts of the body. It tests whether adding a higher dose of radiation to the main tumor helps control the cancer better than standard radiation alone.
Hear when a new Prostate Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.